Medline Inc. MDLN
40.35 USD +6.26 (+18.36%)
At closeNov 4, 2026, 7:52 PM EST
40.31 -0.04 -0.10%
After hours · Nov 4, 7:52 PM ET
37.06 Day range 40.80
31.37 52-week range 50.88
- YTD
- -3.93%
- 1 year
- -1.59%
Financial health
Altman Z-Score
1.81 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 4
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 5
- P/E 2
- P/B 2
Valuation
P/E 29.4×
FY 2022 5y median 28.2× FY 2025
P/S 1.2×
FY 2022 5y median 1.3× FY 2025
P/B 3.2×
FY 2022 5y median 1.9× FY 2025
P/FCF 26.3×
FY 2022 5y median 23.0× FY 2025
EV/EBITDA 19.8×
FY 2022 5y median 16.1× FY 2025
EV/Sales 1.6×
FY 2022 5y median 1.7× FY 2025
FCF Yield 3.8%
FY 2022 5y median 4.1% FY 2025
Profitability
Gross Margin 26.4%
FY 2022 5y median 23.6% FY 2025
Operating Margin 7.8%
FY 2022 5y median 7.0% FY 2025
Net Margin 4.1%
FY 2022 5y median 2.5% FY 2025
ROE 10.8%
FY 2022 5y median 4.3% FY 2025
ROIC 5.7%
FY 2022 5y median 4.7% FY 2025
ROA 3.0%
FY 2022 5y median 1.8% FY 2025
Growth (YoY)
Revenue 11.5%
FY 2022 FY 2025
Operating Income -0.6%
FY 2022 FY 2025
EPS (diluted) -5.9%
FY 2022 FY 2025
Free Cash Flow -7.7%
FY 2022 FY 2025
Financial Health
Current Ratio 4.3×
FY 2022 5y median 3.8× FY 2025
Quick Ratio 2.4×
FY 2022 5y median 2.0× FY 2025
Debt / Equity 1.2×
FY 2022 5y median 1.0× FY 2025
Net Debt / EBITDA 4.7×
FY 2022 5y median 4.7× FY 2025
Interest Coverage 2.7×
FY 2022 5y median 1.4× FY 2025
Dividends
Dividend Yield 1.5%
FY 2022 5y median 0.2% FY 2025
Payout Ratio 44.7%
FY 2022 5y median 22.3% FY 2025
Annual · latest fiscal year ends 2025-12-31